The comparison of inflammatory and oxidative stress biomarkers and FBG showed that patients with gastric cancer had significantly higher values for all measurements, except for anti-inflammatory IL-10, which was significantly higher in the controls, and IL-4, which showed no significant difference (Table 3). The gene discussed is IL4; the disease is gastric cancer.